VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
Nature MedicinePublished 1 October 2000
Peter Carmeliet
Citations366
SJR quartileQ1
SJR score18.33
SNIP8.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The finding that unregulated, continuous delivery of vascular endothelial growth factor to the myocardium causes the formation of hemangiomas and death in mice indicates that more research is required on this potent molecule before clinical trials can proceed.
Abstract
The finding that unregulated, continuous delivery of vascular endothelial growth factor to the myocardium causes the formation of hemangiomas and death in mice indicates that more research is required on this potent molecule before clinical trials can proceed.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
NatureAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
4,142 Citations1996Peter Carmeliet, Valérie Ferreira +14 more
It is reported that formation of blood vessels was abnormal, but not abolished, in heterozygous VEGF-deficient (VEGF+/-) embryos, generated by aggregation of embryonic stem (ES) cells with tetraploid embryos (T-ES)16,17, and even more impaired in homozygous D1-VEGF- deficient (VDGF-/-) T-ES embryos, resulting in death at mid-gestation.
Nature MedicineMechanisms of angiogenesis and arteriogenesis
4,114 Citations2000Peter Carmeliet
The cellular and molecular mechanisms underlying the formation of endothelium-lined channels and their maturation via recruitment of smooth muscle cells (arteriogenesis) during physiological and pathological conditions are summarized, alongside with possible therapeutic applications.
Nature MedicineAngiopoietin-1 protects the adult vasculature against plasma leakage
1,291 Citations2000Gavin Thurston, John S. Rudge +8 more
It is shown that acute administration of angiopoietin-1 does indeed protect adult vasculature from leaking, countering the potentially lethal actions of VEGF and inflammatory agents.
Nature MedicineClinical applications of angiogenic growth factors and their inhibitors
1,008 Citations1999Napoleone Ferrara, Kari Alitalo
Inhibition of the action of key regulators of angiogenesis, such as VEGF, constitutes a promising approach for the treatment of solid tumors and intraocular neovascular syndromes.
The LancetClinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
983 Citations1996Jeffrey M. Isner, Ann Pieczek +8 more
Administration of endothelial cell mitogens promotes angiogenesis in patients with limb ischaemia and intra-arterial gene transfer of a plasmid which encodes for vascular endothelial growth factor can improve blood supply to the ischaemic limb.
DevelopmentVEGF is required for growth and survival in neonatal mice
918 Citations1999Hans‐Peter Gerber, Kenneth J. Hillan +8 more
Endothelial cells isolated from the liver of mFlt(1-3)-IgG-treated neonates demonstrated an increased apoptotic index, indicating that VEGF is required not only for proliferation but also for survival of endothelial cells.
Nature MedicineInhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
797 Citations1999Stéphane Heymans, Aernout Luttun +21 more
Temporary administration of PA inhibitor-1 or the matrix metalloproteinase-inhibitor TIMP-1 completely protected wild-type mice against rupture but did not abort infarct healing, thus constituting a new approach to prevent cardiac rupture after acute myocardial infarction.
CirculationVEGF Gene Delivery to Myocardium
694 Citations2000Randall J. Lee, Matthew L. Springer +4 more
In this model, unregulated continuous expression of VEGF is associated with a high rate of failure to thrive/death and formation of endothelial cell-derived intramural vascular tumors in the implantation site, which underscores the importance of regulating V EGF expression for therapeutic angiogenesis.
CirculationAngiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice
688 Citations1999Karen S. Moulton, Eric A. Heller +4 more
Prolonged treatment with either angiogenesis inhibitor reduced plaque growth and intimal neovascularization in apoE -/- mice, and these results suggest that intimal nvascularization may promote plaque development.
Nature MedicineImpaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
680 Citations1999Peter Carmeliet, Yin‐Shan Ng +17 more
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms V EGF 164 and VEGF 188 is observed.
Laboratory InvestigationHeterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor
416 Citations2000Ånna Pettersson, Janice A. Nagy +13 more
The muscular vessels that developed from mother vessels in skin and perimuscle fat have the structure of collaterals and could be useful clinically in the relief of tissue ischemia and indicate that the angiogenic response induced by VPF/VEGF is heterogeneous and tissue specific.
Molecular CellVEGF Gene Delivery to Muscle
364 Citations1998Matthew L. Springer, Aileen S Chen +3 more
The data suggest that the induction by VEGF of angiogenesis or vasculogenesis may be dose-dependent, and that V EGF expression must be carefully modulated, as overexpression is deleterious.
The Annals of Thoracic SurgeryFocal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121
142 Citations2000Leonard Y. Lee, Shailen R. Patel +11 more
These studies demonstrate that direct intramyocardial administration of Ad(GV)VEGF121.10 results in focal genome and VEGF levels, including focal angiogenesis, sufficient to normalize blood flow to the ischemic myocardium, findings that are relevant to designing human trials of gene therapy-mediated cardiac angiogenic.
The Annual Review of Pharmacology and ToxicologyA Novel Means of Drug Delivery: Myoblast-Mediated Gene Therapy and Regulatable Retroviral Vectors
38 Citations2000Clare R. Ozawa, Matthew L. Springer +1 more
The combination of ex vivo gene transfer using myoblasts and regulatable retroviral vectors provides a powerful toolbox with which to develop gene therapies for a number of human diseases.